Potential for Human Immunodeficiency Virus Parenteral Transmission in the Middle East and North Africa: an Analysis Using Hepatitis C Virus As a Proxy Biomarker

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2014 Oct 4

PMID 25278675

Citations 8

Authors

Yousra A Mohamoud

F DeWolfe Miller

Laith J Abu-Raddad

Affiliations

Soon will be listed here.

Abstract

The Middle East and North Africa (MENA) region has endured several major events of infection parenteral transmission. Recent work has established the utility of using hepatitis C virus (HCV) as a proxy biomarker for assessing the epidemic potential for human immunodeficiency virus (HIV) parenteral transmission. In this review, we use data on the prevalence of HCV infection antibody (seroprevalence) among general population and high risk population groups to assess the potential for HIV parenteral transmission in MENA. Relatively low prevalence of HCV infection in the general population groups was reported in most MENA countries indicating that parenteral HIV transmission at endemic levels does not appear to be a cause for concern. Nonetheless, there could be opportunities for localized HIV outbreaks and transmission of other blood-borne infections in some settings such as healthcare facilities. Though there have been steady improvements in safety measures related to parenteral modes of transmission in the region, these improvements have not been uniform across all countries. More precautions, including infection control training programs, surveillance systems for nosocomial infections and wider coverage and evaluation of hepatitis B virus immunization programs need to be implemented to avoid the unnecessary spread of HIV, HCV, and other blood-borne pathogens along the parenteral modes of transmission.

Citing Articles

Hepatitis C risk score as a tool to identify individuals with HCV infection: a demonstration and cross-sectional epidemiological study in Egypt.

El-Khoury R, Chemaitelly H, Alaama A, Hermez J, Nagelkerke N, Abu-Raddad L BMJ Open. 2024; 14(6):e085506.

PMID: 38950989 PMC: 11340217. DOI: 10.1136/bmjopen-2024-085506.

Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa.

Athamneh R, Arikan A, Sayan M, Mahafzah A, Sallam M Pathogens. 2021; 10(10).

PMID: 34684283 PMC: 8540944. DOI: 10.3390/pathogens10101333.

Key associations for hepatitis C virus genotypes in the Middle East and North Africa.

Mahmud S, Chemaitelly H, Kouyoumjian S, Al Kanaani Z, Abu-Raddad L J Med Virol. 2019; 92(3):386-393.

PMID: 31663611 PMC: 7003848. DOI: 10.1002/jmv.25614.

Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns.

Mahmud S, Al-Kanaani Z, Chemaitelly H, Chaabna K, Kouyoumjian S, Abu-Raddad L J Med Virol. 2017; 90(1):131-141.

PMID: 28842995 PMC: 5724492. DOI: 10.1002/jmv.24921.

Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis.

Heijnen M, Mumtaz G, Abu-Raddad L J Int AIDS Soc. 2016; 19(1):20873.

PMID: 27237131 PMC: 4884676. DOI: 10.7448/IAS.19.1.20873.

References

Hannachi N, Boughammoura L, Marzouk M, Tfifha M, Khlif A, Soussi S . [Viral infection risk in polytransfused adults: seroprevalence of seven viruses in central Tunisia]. Bull Soc Pathol Exot. 2011; 104(3):220-5. DOI: 10.1007/s13149-010-0103-7. View

Akhtar S, Moatter T . Hepatitis C virus infection in polytransfused thalassemic children in Pakistan. Indian Pediatr. 2004; 41(10):1072-3. View

El-Gilany A, El-Fedawy S . Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt. East Mediterr Health J. 2007; 12(6):742-8. View

Hmida S, Mojaat N, Chaouchi E, Mahjoub T, Khlass B, Abid S . [HCV antibodies in hemodialyzed patients in Tunisia]. Pathol Biol (Paris). 1995; 43(7):581-3. View

Al-Faleh F, Ayoola E, Al-Jeffry M, Al-Rashed R, Al-Mofarreh M, Arif M . Prevalence of antibody to hepatitis C virus among Saudi Arabian children: a community-based study. Hepatology. 1991; 14(2):215-8. View

El-Sayed N, Gomatos P, Rodier G, Wierzba T, Darwish A, Khashaba S . Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. Am J Trop Med Hyg. 1996; 55(2):179-84. DOI: 10.4269/ajtmh.1996.55.179. View

Khattak M, Salamat N, Bhatti F, Qureshi T . Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2003; 52(9):398-402. View

ABDEL-WAHAB M, Zakaria S, Kamel M, Mabrouk M, Salama H, Esmat G . High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg. 1994; 51(5):563-7. DOI: 10.4269/ajtmh.1994.51.563. View

Khattab M, Eslam M, Sharwae M, Hamdy L . Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008. Am J Infect Control. 2010; 38(8):640-1. DOI: 10.1016/j.ajic.2009.12.016. View

10.

Farawela H, Khorshied M, Shaheen I, Gouda H, Nasef A, Abulata N . The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt. Infect Genet Evol. 2012; 12(6):1189-94. DOI: 10.1016/j.meegid.2012.04.007. View

11.

Gul U, Kilic A, Sakizligil B, Aksaray S, Bilgili S, Demirel O . Magnitude of sexually transmitted infections among female sex workers in Turkey. J Eur Acad Dermatol Venereol. 2008; 22(9):1123-4. DOI: 10.1111/j.1468-3083.2007.02548.x. View

12.

Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N . [Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca]. Nephrol Ther. 2006; 1(5):274-84. DOI: 10.1016/j.nephro.2005.06.012. View

13.

el Guneid A, Gunaid A, ONeill A, Zureikat N, Coleman J, Murray-Lyon I . Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. J Med Virol. 1993; 40(4):330-3. DOI: 10.1002/jmv.1890400413. View

14.

Novelli V, Mostafavipour H, Abulaban M, Ekteish F, Milder J, Azadeh B . High prevalence of human immunodeficiency virus infection in children with thalassemia exposed to blood imported from the United States. Pediatr Infect Dis J. 1987; 6(8):765-6. View

15.

Abdul Mujeeb S, Aamir K, Mehmood K . Seroprevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc. 2000; 50(8):269-70. View

16.

Gholamreza R, Shahryar S, Abbasali K, Hamidreza J, Abdolvahab M, Khodaberdi K . Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian J Med Sci. 2007; 61(5):263-8. View

17.

Ali S, Donahue R, Qureshi H, Vermund S . Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2008; 13(1):9-19. PMC: 2651958. DOI: 10.1016/j.ijid.2008.06.019. View

18.

Bile K, ADEN C, Norder H, Magnius L, Lindberg G, Nilsson L . Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia. Scand J Infect Dis. 1993; 25(5):559-64. DOI: 10.3109/00365549309008543. View

19.

Shaheen F, Huraib S, Al-Rashed R, Aldrees A, Arif M, Al Jeffry M . Prevalence of hepatitis C antibodies among hemodialysis patients in the Western province of saudi arabia. Saudi J Kidney Dis Transpl. 1995; 6(2):136-9. View

20.

Watts D, Constantine N, Sheba M, Kamal M, Callahan J, Kilpatrick M . Prevalence of HIV infection and AIDS in Egypt over four years of surveillance (1986-1990). J Trop Med Hyg. 1993; 96(2):113-7. View